Abstract:10-Hydroxycamptothecin (HCPT) is a well-established topoisomerase I inhibitor of a broad spectrum of cancers. However, poor aqueous solubility, low instability, and toxicity to normal tissues have limited its clinical development. A novel HCPT-containing drug carrier system was developed to overcome these disadvantages. The response surface methodology was used to optimize the process of preparing HCPT–chitosan nanoparticles (HCPT–CSNPs) by the SAS-ionic crosslink (supercritical antisolvent SAS) combination method; the resulting HCPT–CSNPs were then conjugated with folate for specific targeting. A central composite design, composed of four independent variables, namely, chitosan concentration, TPP concentration, HCPT nanoparticle concentration, and crosslink time, was applied in the modeling process. The mean particle size and drug entrapment efficiency (DEE) of HCPT–CSNPs were chosen as response variables. The interactive effects of the four independent variables on the response variables were also studied. Nanoparticle characteristics such as morphology, DEE, and mean particle size were investigated. The optimum conditions for preparing HCPT–CSNPs were determined as follows: folate-coupled chitosan concentration 2.46mg/ml, TPP concentration 7.73mg/ml, HCPT nanoparticle concentration 0.48mg/ml, and crosslinking time 47.4min. Optimum conditions for preparing desired HCPT–CSNPs with a mean particle size of 173.5nm and entrapment efficiency of 77.3% were obtained. The resulting folate-conjugated HCPT–CSNPs (FA–HCPT–CSNPs) reveal that the amount of folate conjugation was 197.64mg/g CS. FA–HCPT–CSNPs used in drug carrier systems could have potential value in HCPT-sensitive tumors.

A Novel Preparation Method For Camptothecin (Cpt) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles

Synthesis of Folate-conjugated Stearic Acid Grafted Bletilla Striata Polysaccharides Copolymers and Application for Delivering Antitumor Drugs As a Drug Delivery Carrier

Process Optimization Studies of 10-Hydroxycamptothecin (Hcpt)-Loaded Folate-Conjugated Chitosan Nanoparticles by SAS-ionic Crosslink Combination Using Response Surface Methodology (RSM)

Preparation of Folic Acid-conjugated Pirarubicin-loaded Dextran Nanoparticles by Supercritical Antisolvent Method

Dextran-coated superparamagnetic nanoparticles modified with folate for targeted drug delivery of camptothecin

Preparation, Characterization and Targeting of Micronized 10-Hydroxycamptothecin-loaded Folate-Conjugated Human Serum Albumin Nanoparticles to Cancer Cells.

Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on alpha,beta-poly[(N-carboxybutyl)-L-aspartamide]-camptothecin conjugate.

Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process

Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on α,β-poly[(N-carboxybutyl)-l-aspartamide]–camptothecin conjugate

Preparation and Properties of Conjugate of Dextran Coupled with Hydroxycamptothecin

Preparation, Formula Optimization and Antitumor Actions of Mannitol Coupling Camptothecin Nanoparticles

Preparation and Functional Characterization of Tumor-Targeted Folic Acid-Chitosan Conjugated Nanoparticles Loaded with Mitoxantrone

Folic Acid-Decorated Β-Cyclodextrin-based Poly(ε-caprolactone)-dextran Star Polymer with Disulfide Bond-Linker As Theranostic Nanoparticle for Tumor-Targeted MRI and Chemotherapy.

Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.

Improved camptothecin encapsulation and efficacy by environmentally sensitive block copolymer/chitosan/fucoidan nanoparticles for targeting lung cancer cells

Preparation of Camptothecin-Loaded Targeting Nanoparticles and Their Antitumor Effects on Hepatocellular Carcinoma Cell Line H22.

Preparation of camptothecin micelles self-assembled from disodium glycyrrhizin and tannic acid with enhanced antitumor activity

Preparation and Antitumor Study of Camptothecin Nanocrystals

Preparation and Characterization of Pluronic/TPGS Mixed Micelles for Solubilization of Camptothecin.

In Vitro and in Vivo Evaluation of Camptothecin Nanosuspension: a Novel Formulation with High Antitumor Efficacy and Low Toxicity.